SNTI Senti Biosciences Holdings, Inc.
-
Senti Biosciences Missed Consensus Estimates
Friday, August 14, 2026 · 12:00 AM ET
Senti Biosciences (SNTI) reported a loss of $0.41 per share on revenue of $0.02 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.33 per share on revenue of $0.10 million. The company missed consensus estimates by 24.24%.
Senti Biosciences Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform. Senti Biosciences Inc., formerly known as Dynamics Special Purpose Corp., is based in SOUTH SAN FRANCISCO, Calif.
Reported Earnings
($0.41)
Earnings Whisper®
—
Consensus Estimate
($0.33)
Earnings Surprise
Earnings Growth
Reported Revenue
$0.02M
Revenue Estimate
$0.10M
Revenue Surprise
Revenue Growth—